Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
Clinical trial NCT06618196 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06618196
- Sponsor
- LG Chem
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-02
- Primary completion
- 2025-06-30
- Enrollment
- 336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.